BioAlliance Pharma : a Growing SME Receives a Prestigious Award from the French State

PARIS--(Marketwire - September 19, 2008) - BioAlliance Pharma SA (Euronext Paris, ISIN code: FR0010095596-BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced that Madame Dominique Costantini, President of the company’s Executive Board, had been awarded the Knight of the Legion of Honor insignia by Professor Claude Griscelli, a former Director of France’s INSERM national institute of health and a member of the country’s State Council.

MORE ON THIS TOPIC